Download the new Dimensions White Paper to discover the current and emerging research trends in Pharma.
This White Paper ranks social media platforms, demonstrates how life science companies are adapting to the digital world, defines the digital opinion leader and how to find one, and provides 4 key takeaways that you can start implementing right away.
Thank you MAPS Partner Circle members for sharing use cases that bring to life MAPS’ Vision for Generative Artificial Intelligence in Medical Affairs.
This article summarizes CRA’s roundtable discussion with Medical Affairs leaders in Lisbon, which focused on transitioning Medical Affairs to a function that is co-leading strategically the clinical development and commercialization efforts.
In this Within3 White Paper, learn how your team can work toward operational excellence for Medical Affairs, despite ever-shifting roles.
How can the Medical Affairs function overcome critical pain points with digital and AI tools?
With the advent of the digital age, Share of Voice has come to mean more than just numbers. Learn how to accurately measure Share of Voice in a digital age.
To better understand MAPS members’ perspectives on AI, Open Health recently convened a panel discussion on the future of data, AI, and analytics in Medical Affairs.
In today’s rapidly evolving pharmaceutical environment, Medical Affairs teams are under increasing pressure to understand how to go beyond “activity engagement” metrics and identify areas of opportunity to advance evidenced-based medicine and treatment with current available data.
This webinar will provide a historical perspective on value, as well as insights to help Medical Affairs professionals measure and demonstrate the impact of their activities in a complex environment.
As Medical Affairs teams strive to identify areas of opportunity and demonstrate their value, understanding the importance of data-driven strategies is essential. In this webinar, we will discuss the historical perspective on value in Medical Affairs, as well as strategies to measure and demonstrate impact in an evolving pharmaceutical environment. Join us to learn more about how data-driven strategies can help you gain a better understanding of your Medical Affairs activities and provide insights into areas of opportunity.
In this white paper, Triducive asks: Where is MA now? How are we progressing? Which areas may need the greatest additional effort/support?